Kensington Investment Counsel’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-12,681
| Closed | -$1.21M | – | 110 |
|
|
2024
Q1 | $1.21M | Sell |
12,681
-6,019
| -32% | -$575K | 0.55% | 59 |
|
|
2023
Q4 | $1.43M | Sell |
18,700
-105
| -0.6% | -$8.01K | 0.75% | 50 |
|
|
2023
Q3 | $1.3M | Buy |
18,805
+153
| +0.8% | +$10.6K | 0.81% | 45 |
|
|
2023
Q2 | $1.76M | Sell |
18,652
-221
| -1% | -$20.8K | 1.12% | 33 |
|
|
2023
Q1 | $1.56M | Sell |
18,873
-1,295
| -6% | -$107K | 1.18% | 35 |
|
|
2022
Q4 | $1.5M | Sell |
20,168
-333
| -2% | -$24.8K | 1.18% | 37 |
|
|
2022
Q3 | $1.69M | Sell |
20,501
-5
| -0% | -$413 | 1.43% | 29 |
|
|
2022
Q2 | $1.95M | Sell |
20,506
-455
| -2% | -$43.3K | 1.66% | 19 |
|
|
2022
Q1 | $2.47M | Sell |
20,961
-1,414
| -6% | -$166K | 1.63% | 15 |
|
|
2021
Q4 | $2.9M | Buy |
+22,375
| New | +$2.9M | 1.69% | 14 |
|
|
2021
Q2 | $2.15M | Buy |
20,736
+466
| +2% | +$48.3K | 1.47% | 20 |
|
|
2021
Q1 | $1.7M | Buy |
20,270
+895
| +5% | +$74.8K | 1.27% | 32 |
|
|
2020
Q4 | $1.77M | Buy |
+19,375
| New | +$1.77M | 1.46% | 19 |
|